Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Mutant Asp251Gly/Gln307His of Cytochrome P450 BM3 for the Generation of Metabolites of Diclofenac, Ibuprofen and Tolbutamide

15 Feb 2012

Abstract excerpt

The soluble, catalytically self-sufficient cytochrome P450 BM3 from Bacillus megaterium is a good candidate as biocatalyst for the synthesis of drug metabolites. To this end, error-prone polymerase chain reaction (PCR) was used to generate a library of P450 BM3 mutants with novel activities toward drugs. The double mutant Asp251Gly/Gln307His (A2) with activities towards diclofenac, ibuprofen and tolbutamide was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22337118
DOI: 10.1002/chem.201102470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Mutant Asp251Gly/Gln307His of Cytochrome P450 BM3 for the Generation of Metabolites of Diclofenac, Ibuprofen and TolbutamidePMID 22337118Read ↗

Subtle structural changes in the Asp251Gly/Gln307His P450 BM3 mutant responsible for new activity toward diclofenac, tolbutamide and ibuprofen.Semantic proximity Read ↗

Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis.Semantic proximity Read ↗

Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants.Semantic proximity Read ↗

Biotransformation of beta-ionone by engineered cytochrome P450 BM-3.Semantic proximity Read ↗

Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.Semantic proximity Read ↗

Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.Semantic proximity Read ↗

Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.Semantic proximity Read ↗

P450(BM3) (CYP102A1): connecting the dots.Semantic proximity Read ↗

Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.Semantic proximity Read ↗

High throughput assay for cytochrome P450 BM3 for screening libraries of substrates and combinatorial mutants.Semantic proximity Read ↗

Transformation of the drug ibuprofen by <i>Priestia megaterium</i> : Reversible glycosylation and generation of hydroxylated metabolitesSemantic proximity Read ↗

Characterization of diverse natural variants of CYP102A1 found within a species of Bacillus megateriumSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.